Wednesday - May 20, 2026
FDA Center for Drug Evaluation & Research Issues Warning Letter to Sourav K. Mishra, M.D./All India Institute of Medical Sciences
May 20, 2026
WASHINGTON, May 20 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Sourav K. Mishra, M.D. / All India Institute of Medical Sciences from its Center for Drug Evaluation and Research:

* * *

Recipient: Sourav K. Mishra, M.D., Sourav K. Mishra, M.D. / All India Institute of Medical Sciences, Sijua, Patrapada, Bhubaneswar 751019 Odisha, India

Issuing Office: Center for Drug Evaluation and Re . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products